These Analysts Think Synchronoss Technologies, Inc.'s (NASDAQ:SNCR) Sales Are Under Threat

The latest analyst coverage could presage a bad day for Synchronoss Technologies, Inc. ( NASDAQ:SNCR ), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little shell-shocked. This report focused on revenue estimates, and it looks as though the consensus view of the business has become substantially more conservative. Notably, revenue forecasts were likely revised downward due to the strategic divestment of non-core business segments.

Following the latest downgrade, the three analysts covering Synchronoss Technologies provided consensus estimates of US$227m revenue in 2024, which would reflect a noticeable 4.8% decline on its sales over the past 12 months. Before the latest update, the analysts were foreseeing US$255m of revenue in 2024. It looks like forecasts have become a fair bit less optimistic on Synchronoss Technologies, given the substantial drop in revenue estimates.

Check out our latest analysis for Synchronoss Technologies

earnings-and-revenue-growth
NasdaqCM:SNCR Earnings and Revenue Growth November 9th 2023

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would also point out that the forecast 3.9% annualised revenue decline to the end of 2024 is better than the historical trend, which saw revenues shrink 6.8% annually over the past five years By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 12% per year. So it's pretty clear that, while it does have declining revenues, the analysts also expect Synchronoss Technologies to suffer worse than the wider industry.

Advertisement

The Bottom Line

The clear low-light was that analysts slashing their revenue forecasts for Synchronoss Technologies next year. They're also anticipating slower revenue growth than the wider market. Given the stark change in sentiment, we'd understand if investors became more cautious on Synchronoss Technologies after today.

Of course, this isn't the full story. We have estimates for Synchronoss Technologies from its three analysts out until 2024, and you can see them free on our platform here.

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying .

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqCM:SNCR

Synchronoss Technologies

Provides white label cloud software and services in North America, Europe, the Middle East, Africa, and the Asia Pacific.

Undervalued with moderate growth potential.

Advertisement

Weekly Picks

ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Looking to be second time lucky with a game-changing new product

Fair Value:US$21.5362.1% undervalued
132 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
DE
Degen_GCR
P logo
Degen_GCR on Everpure ·

Second order memory play likely to double in a year

Fair Value:US$18053.7% undervalued
5 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
DO
Double_Bubbler
LUNR logo
Double_Bubbler on Intuitive Machines ·

Intuitive Machines: To The Moon and Beyond!

Fair Value:US$42.324.1% undervalued
4 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
YI
APP logo
yiannisz on AppLovin ·

AppLovin’s AI Engine Is Printing Profit

Fair Value:US$989.2450.4% undervalued
22 users have followed this narrative
1 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

OI
MVO logo
Oily on MV Oil Trust ·

Poor analysis here will mislead investors

Fair Value:US$2.11.0% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ZH
zhalia
LYC logo
zhalia on Lynas Rare Earths ·

Lynas Rare Earths to Shine with 281% Future P/E Surge

Fair Value:AU$22.8714.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
kapirey
ROP logo
kapirey on Roche Holding ·

Roche is a cash-generating, defensive large-cap pharma, with upside driven by pipeline execution.

Fair Value:CHF 353.349.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8590.1% undervalued
108 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.227.7% undervalued
70 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$74018.5% undervalued
35 users have followed this narrative
3 users have commented on this narrative
33 users have liked this narrative